Tag Archives: Canaccord Genuity Musculoskeletal Conference

Business, Finance, Occupation & Industry

Exactech to Showcase Innovations in Joint Replacement During AAOS Annual Conference in Chicago

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Exactech to Showcase Innovations in Joint Replacement During AAOS Annual Conference in Chicago


CEO Dr. Bill Petty to Present at Canaccord Genuity Conference

GAINESVILLE, Fla.–(BUSINESS WIRE)– Exactech, Inc. (NAS: EXAC) , which designs and manufactures bone and joint restoration products for hip, knee, shoulder and spine procedures, announced today that Exactech Chief Executive Officer Bill Petty, MD, will discuss the company’s financial highlights at Canaccord Genuity’s Musculoskeletal Conference in Chicago on March 19, 2013.

Exactech recently announced the company’s 2012 financial results that continue to surpass the overall growth of the company’s peers. Leading the way has been the Equinoxe® shoulder system, which for several years has been the fastest growing shoulder replacement system in the U.S.

Exactech growth also continues to be fueled by the introduction of new solutions for bone and joint reconstruction. Many of these products will be on display during the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting at the company’s Booth # 4612, March 20 – 22, 2013, in Chicago. Additional details about Exactech and the products being showcased are available at https://www.exac.com/medical-professionals/academy-2013.

Shoulder

Learn more about the industry’s fastest growing shoulder system, Exactech’s Equinoxe® Platform Shoulder System as the company celebrates global “Equinoxe Day,” Wednesday, March 20. Just as the spring equinox on this date represents equal balance of day and night, Exactech’s Equinoxe shoulder system is designed to achieve balance in the shoulder joint. The Equinoxe Platform Shoulder System delivers innovative solutions to clinical challenges. The product family includes treatment options for both degenerative disease (primary and reverse total shoulder systems) as well as trauma (platform fracture stem and fracture plate). Throughout the AAOS exhibit time, design team surgeons and key clinicians will be on hand to share their experiences and provide product and instrument demonstrations and media interviews. Be among the first to see the latest additions to the Equinoxe product family:

Business, Finance, Occupation & Industry

Globus Medical to Present at the Canaccord Genuity Musculoskeletal Conference

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Globus Medical to Present at the Canaccord Genuity Musculoskeletal Conference

AUDUBON, Pa.–(BUSINESS WIRE)– Globus Medical, Inc. (NYS: GMED) , a leading spinal implant manufacturer, today announced that Dave Demski, President and Chief Operating Officer, and Richard Baron, Senior Vice President and Chief Financial Officer, will present at the 2013 Canaccord Genuity Musculoskeletal Conference on Tuesday, March 19, 2013 at 2:30 p.m. ET (1:30 PM CT) at the Westin Michigan Avenue, in Chicago, IL.

Interested institutional investors that wish to schedule a meeting should contact Canaccord Genuity.

About Globus Medical, Inc.

Globus Medical, Inc. is a leading spinal implant company based in Audubon, PA. The company was founded in 2003 by an experienced team of spine professionals with a shared vision to create products that enable spine surgeons to promote healing in patients with spinal disorders. Additional information can be accessed at www.globusmedical.com.

Globus Medical, Inc.
Ed Joyce, 610-930-1800
investors@globusmedical.com
www.globusmedical.com

KEYWORDS:   United States  North America  Pennsylvania

INDUSTRY KEYWORDS:

The article Globus Medical to Present at the Canaccord Genuity Musculoskeletal Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
return true;
…read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Osiris Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Osiris Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference

COLUMBIA, Md.–(BUSINESS WIRE)– Osiris Therapeutics, Inc. (NAS: OSIR) , the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2013 Canaccord Genuity Musculoskeletal Conference on Tuesday, March 19, 2013 at 9:30 a.m. ET (8:30 a.m. CT) in Chicago.

A live webcast of the presentation may be accessed through the Investors page of the Company’s website at www.Osiris.com. A replay of the webcast will be available for one week following the conference. Also, if in Chicago, please visit Osiris at booth 207 of McCormick Place for the Annual Meeting of The American Academy of Orthopaedic Surgeons, March 20-22.

About Osiris Therapeutics

Osiris Therapeutics, Inc., having developed the world’s first approved stem cell drug, Prochymal®, is the leading stem cell company. The company is focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets. In Biosurgery, Osiris currently markets Grafix® for acute and chronic wounds, and Ovation® and Cartiform for orthopedic applications. Osiris is a fully integrated company with capabilities in research, development, manufacturing and distribution of cellular products. Osiris has developed an extensive intellectual property portfolio to protect the company’s technology, including 50 U.S. and 156 foreign patents.

Osiris, Prochymal, Chondrogen, Grafix and Ovation are registered trademarks of Osiris Therapeutics, Inc. More information can be found on the company’s website, www.Osiris.com. (OSIR-G)

Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. Words or phrases such as “anticipate,” “believe,” “continue,” “ongoing,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project” or similar words or phrases, or the negatives of those words or phrases, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward-looking. Examples of forward-looking statements may include, without limitation, statements regarding any of the following: our product development efforts; our clinical trials and anticipated regulatory requirements, and our ability to successfully navigate these requirements; the success of our product candidates in development; status of …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on March 19

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on March 19

Presentation to be Webcast Live at 3:30 p.m. ET / 2:30 p.m. CT

BEDFORD, Mass.–(BUSINESS WIRE)– Anika Therapeutics, Inc. (NAS: ANIK) a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA“) technology, today announced that Chief Executive Officer Dr. Charles Sherwood will be presenting at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 19, 2013 at 3:30 p.m. ET / 2:30 p.m. CT. The conference is being held at the Westin Michigan Avenue in Chicago.

An audio webcast of the presentation will be available live and may be accessed via the “Investor Relations” section of Anika’s website at www.anikatherapeutics.com. An archive of the presentation also will be available on the website.

About Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika’s products range from orthopedic/joint health solutions led by Orthovisc®, a treatment for osteoarthritis of the knee; to surgical aids in the ophthalmic and anti-adhesion fields. The company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika’s Italian subsidiary, Anika Therapeutics S.r.l, provides complementary HA products in orthopedic/joint health and anti-adhesion, as well as therapeutics in areas such as advanced wound treatment and ear, nose and throat care. Its regenerative tissue technology advances Anika’s vision to offer therapeutic products that go beyond pain relief to protect and restore damaged tissue.

Anika Therapeutics, Inc.
Charles H. Sherwood, Ph.D., 781-457-9000
President and CEO

KEYWORDS:   United States  North America  Illinois  Massachusetts

INDUSTRY KEYWORDS:

The article Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on March 19 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The …read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

Orthofix to Participate in the Canaccord Genuity Musculoskeletal Conference

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

Orthofix to Participate in the Canaccord Genuity Musculoskeletal Conference

LEWISVILLE, Texas–(BUSINESS WIRE)– Orthofix International N.V., (NAS: OFIX) (the Company) announced today that it will be participating in the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 19th at 8:50 a.m. Central Time at The Westin Michigan Avenue in Chicago, IL.

A live audio webcast will be available on the Company’s website at www.orthofix.com by clicking on the Investors tab and then clicking the link on the Events & Presentations page.


About Orthofix:

Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofix’s products are widely distributed around the world to surgeons and patients via Orthofix’s sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com.

Orthofix International N.V.
Mark Quick, 214-937-2924
Director of Investor Relations and Business Development
markquick@orthofix.com

KEYWORDS:   United States  North America  Illinois  Texas

INDUSTRY KEYWORDS:

The article Orthofix to Participate in the Canaccord Genuity Musculoskeletal Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");

function addEvent(obj, evType, fn, useCapture){
…read more
Source: FULL ARTICLE at DailyFinance

Business, Finance, Occupation & Industry

ArthroCare Announces Participation in Investor Conference

Leave a comment

By Business Wirevia The Motley Fool

Filed under:

ArthroCare Announces Participation in Investor Conference

AUSTIN, Texas–(BUSINESS WIRE)– ArthroCare Corp. (NAS: ARTC) , a leader in developing state-of-the-art, minimally invasive surgical products, announced today participation in an upcoming investor conference, as detailed below.

On Tuesday, March 19, 2013 ArthroCare will present during the Canaccord Genuity Musculoskeletal Conference. David Fitzgerald, President and Chief Executive Officer, will deliver the business presentation. Please see the conference details below.

Canaccord Genuity Musculoskeletal Conference

  • Date: Tuesday, March 19, 2013
  • Time: 9:30 a.m. CT
  • Location: Chicago, IL

The presentation will be webcast live and can be accessed on ArthroCare’s website at www.arthrocare.com. The webcast will remain available for 30 days following the presentation.

ABOUT ARTHROCARE

ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare’s devices use its internationally patented Coblation® technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS® line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.


FORWARD-LOOKING STATEMENTS

The information provided herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on beliefs and assumptions by management and on information currently available to management. Forward-looking statements speak only as of the date …read more
Source: FULL ARTICLE at DailyFinance